BioNTech expects results by September from trials testing the Covid-19 vaccine that it and Pfizer have developed in babies as young as six months old, German magazine Spiegel cited the company's CEO as saying.

"In July, the first results could be available for the five to 12-year-olds, in September for the younger children," BioNTech chief executive Ugur Sahin told Spiegel. He added it takes about four to six weeks to evaluate the data.

"If all goes well, as soon as the data is evaluated, we will be able to...